Molecular mechanisms of dissociative glucocorticoid activity

European Journal of Clinical Investigation, Supplement

Volumn 30, Issue 3, 2000, Pages 6-9

  Bamberger, Christoph ^a,c   Schulte, H M ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ENDOKRINOLOGIKUM HAMBURG   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Acetate; Dissociative glucocorticoids; Medroxyprogesterone; Transactivation; Transrepression

Indexed keywords

DEXAMETHASONE; GESTAGEN; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 2; IONOMYCIN; LUCIFERASE; MEDROXYPROGESTERONE ACETATE; PHORBOL ESTER; PHYTOHEMAGGLUTININ; PROGESTERONE; STEROID;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG SPECIFICITY; ELECTROPORATION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION;

EID: 0034477278     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.0300s3006.x     Document Type: Conference Paper

References (35)

1. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
2. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease
3. Glucocorticosteroid action on the immune system: Molecular and cellular aspects
4. The steroid and thyroid hormone receptor superfamily
5. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
6. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
7. Steroid Hormone Receptors: Many actors in search of a plot
8. The nuclear receptor superfamily: The second decade
9. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
10. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone
11. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids
12. Mechanisms for inducible control of angiotensinogen gene transcription
13. Transcriptional regulation of the human leukemia inhibitory factor gene: Modulation by glucocorticoids and estradiol
14. Negative regulation of interleukin transcription by the glucocorticoid receptor
15. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements
16. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transciption factors AP-1 and NF-AT
17. Antitumor promotion and antiinflammation: Downmodulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
18. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor
19. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
20. Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors
21. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes
22. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog
23. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells
24. Regulation of the human interleukin-2 (IL-2) gene by the alpha and beta isoforms of the glucocorticoid receptor
25. Dissociative glucocorticoid activity of medroxyprogesterone acetate (MPA) in normal human lymphocytes
26. Effect of synthetic progestational agents on allograft rejection and circulating antibody production
27. Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy
28. Progesterone-induced immunosuppression is not mediated through the progesterone receptor
29. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients
30. Expression of the gene coding for the progesterone receptor in activated human Lymphozytes
31. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentrations
32. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
33. The influence of high doses of oral medroxyprogesterone acetate on glucose tolerance, serum insulin levels and adrenal response to ACTH. A study of 17 patients under treatment for endometrial cancer
34. Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing hormone
35. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate